Minor Pack AMS1374(A, CMP1560, PSS3517, PSS3517(A, PSS3518, PSS3518(A, PSS3541, and PSS3541(A. c...
FDA Device Recall #Z-0242-2017 — Class II — April 22, 2015
Recall Summary
| Recall Number | Z-0242-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 22, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Windstone Medical Packaging, Inc. |
| Location | Billings, MT |
| Product Type | Devices |
| Quantity | 1025 kits |
Product Description
Minor Pack AMS1374(A, CMP1560, PSS3517, PSS3517(A, PSS3518, PSS3518(A, PSS3541, and PSS3541(A. convenience custom kits used for general surgery in hospital operating room
Reason for Recall
The Medtronic COVER LIGHT HANDLE DISPOSABLE GLOVES, Part # 13140, of the custom AMS kit were recalled because gloves may contain splits or holes compromising sterility.
Distribution Pattern
Nationwide Distribution to California, Florida, Georgia, Illinois, Kansas, Louisiana, Michigan, New Jersey, Nevada, Texas, Virginia, and Wyoming.
Lot / Code Information
Lot Numbers/Expiration Dates: 59360 4/4/2015 60180 7/22/2015 60972 8/20/2015 60716 9/20/2015 61627 10/15/2015 65729 11/15/2015 65371 11/18/2015 62925 11/26/2015 64759 12/26/2015 63807 1/14/2016 64511 1/16/2016 65907 7/11/2016 57777 7/16/2016 67561 8/26/2016 69460 9/11/2016 69554 11/9/2016 72302 1/5/2017 71984 1/27/2017 73801 4/2/2017 74579 4/23/2017 78211 4/26/2017 74831 5/23/2017 74685 5/24/2017 74462 5/25/2017 74578 5/26/2017 75514 7/2/2017 77373 7/19/2017 78511 8/6/2017 75602 9/19/2017 79095 11/4/2017 79588 11/20/2017 79682 1/17/2018 79251 1/26/2018 81260 2/13/2018 80649 2/27/2018
Other Recalls from Windstone Medical Packaging, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0031-2025 | Class II | Aligned Medical Tonsil Pack REF AMS14809 that c... | Aug 16, 2024 |
| Z-0030-2025 | Class II | Aligned Medical T and A Pack REF AMS11482 that ... | Aug 16, 2024 |
| Z-0027-2025 | Class II | Aligned Medical Tonsil Tray REF AMS9300A that c... | Aug 16, 2024 |
| Z-0028-2025 | Class II | Aligned Medical Tonsil ENT Pack REF AMS9977 tha... | Aug 16, 2024 |
| Z-0029-2025 | Class II | Aligned Medical Septo Pack REF AMS11480 that co... | Aug 16, 2024 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.